🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Top ASX Stocks for this Month

Published 04/04/2024, 03:48 am
© Reuters.  Top ASX Stocks for this Month
AXJO
-
NEM
-
MESO
-

If you've been hesitant to dive into the market and missed out on the 3.45% gains already delivered by the S&P/ASX 200 Index (ASX: XJO) so far in 2024, don't worry! Now is an excellent time to consider adding some new investments to your portfolio.

However, it's crucial to remember the importance of diversification when buying ASX shares. Putting all your eggs in one basket can be risky, so spreading your investments across a range of stocks is prudent.

Our team of analysts has scoured the market to bring you a selection of top ASX shares for April 2024, listed from smallest to largest market capitalizations:

Mesoblast Ltd (ASX: MSB) - Market Cap: $631.37 million

Mesoblast is a clinical-stage biotech company focused on developing allogeneic cellular medicines to treat diseases resistant to conventional care. Recent positive developments, including progress with the FDA, could lead to further share price gains.

Accent Group Ltd (ASX: AX1) - Market Cap: $1.14 billion

Accent Group is a distributor of international shoe brands in Australia, with its own retail businesses. Despite recent challenges, it is well-positioned to rebound when retail conditions improve.

PSC Insurance Group Ltd (ASX: PSI) - Market Cap: $1.98 billion

PSC Insurance Group operates in the insurance sector across Australia, New Zealand, and the United Kingdom, serving small and medium-sized enterprises. With a track record of growth and potential bid interest, it could be undervalued by the public markets.

Neuren Pharmaceuticals Ltd (ASX: NEU) - Market Cap: $2.71 billion

Neuren Pharmaceuticals develops treatments for rare neurological conditions. Despite recent setbacks, analysts remain optimistic about its growth prospects.

Xero Ltd (ASX: XRO) - Market Cap: $20.23 billion

Xero provides cloud-based accounting software for small businesses globally. With a vast addressable market and positive outlook, it could continue to deliver strong growth in the long term.

Newmont Corporation (ASX: NEM) - Market Cap: $61.9 billion

Newmont is one of the largest gold miners globally, with significant reserves and low production costs. Despite recent declines in the share price, it could present value, especially if gold prices remain high.

Goodman Group (ASX: GMG) - Market Cap: $64.21 billion

Goodman is Australia's largest real estate investment trust (REIT), specializing in global industrial property. With strong demand in the industrial sector, it remains well-positioned for continued success.

These are just a few options to consider, and it's essential to conduct thorough research and consider your investment goals before making any decisions.

When considering investing in ASX shares, it's vital to understand the factors driving each company's performance and the broader market trends. Additionally, diversification across different sectors and industries can help mitigate risks associated with individual stocks.

Mesoblast Ltd, for example, is a biotech company with a focus on developing innovative treatments for diseases resistant to conventional care. Recent positive developments, such as progress with the FDA, have boosted investor confidence in the company's prospects.

Similarly, Accent Group Ltd operates in the retail sector, distributing international shoe brands and owning its retail businesses. Despite challenges in the retail environment, Accent Group's diverse portfolio and potential for rebound make it an attractive option for investors.

PSC Insurance Group Ltd, operating in the insurance sector, has shown consistent growth and profitability since its founding. With its focus on serving small and medium-sized enterprises across multiple regions, PSC Insurance Group presents a compelling investment opportunity.

Neuren Pharmaceuticals Ltd, despite recent setbacks, remains a high-growth prospect in the biotech industry. With its focus on developing treatments for rare neurological conditions, Neuren Pharmaceuticals has attracted attention from analysts and investors alike.

Xero Ltd, a leading provider of cloud-based accounting software, offers investors exposure to the growing small business market globally. With its strong market position and growth potential, Xero is well-positioned for continued success in the long term.

Newmont Corporation, as one of the largest gold miners globally, offers investors exposure to the precious metals market. Despite recent declines in the share price, Newmont's significant reserves and low production costs make it an attractive option, especially in a high-price environment.

Finally, Goodman Group, as Australia's largest REIT specializing in industrial property, offers investors exposure to the growing digital economy and artificial intelligence sectors. With strong demand for industrial properties, Goodman Group is well-positioned for continued growth and success.

In conclusion, these seven ASX shares offer investors a diverse range of investment opportunities across various sectors and industries. However, it's essential to conduct thorough research and consider your investment goals and risk tolerance before making any investment decisions.

Read more on Kalkine Media

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.